Alternate Endpoints for Phase II Trials in Advanced Neuroendocrine Tumors.
Imaoka H, Sasaki M, Takahashi H, Hashimoto Y, Ohno I, Mitsunaga S, Watanabe K, Umemoto K, Kimura G, Suzuki Y, Kan M, Ikeda M.
Imaoka H, et al. Among authors: takahashi h.
Oncologist. 2019 Jan;24(1):47-53. doi: 10.1634/theoncologist.2017-0651. Epub 2018 Aug 2.
Oncologist. 2019.
PMID: 30072388
Free PMC article.
Clinical Trial.